The impact of integrase inhibitors on steatosis and fibrosis biomarkers in persons with HIV naïve to antiretroviral therapy

The impact of integrase inhibitors on steatosis and fibrosis biomarkers in persons with HIV naïve to antiretroviral therapy

Abstract Background Non-alcoholic Fatty Liver Disease (NAFLD) has a high prevalence among persons with HIV infection. Since Integrase Strand Transfer Inhibitors (INSTIs) are used worldwide and have been associated with weight gain, we must determine their effect in the development of NAFLD and Non-a...

Full description

Bibliographic Details
Main Authors: Sara Rodrigues Fernandes, Ana Rita Leite, Rita Lino, André Rodrigues Guimarães, Carmela Pineiro, Rosário Serrão, Paula Freitas
Format: Article
Language:English
Published: BMC 2023-08-01
Series:BMC Infectious Diseases
Subjects:
HIV
Integrase strand transfer inhibitors
Non-alcoholic fatty liver disease
Steatosis
Liver fibrosis
Online Access:https://doi.org/10.1186/s12879-023-08530-3

Internet

https://doi.org/10.1186/s12879-023-08530-3

Similar Items